Meridian Bioscience - 26 Year Stock Price History | VIVO

Historical daily share prices for Meridian Bioscience since 1992 adjusted for splits and dividends. Open, high, low, close (OHLC) data as well as percentage changes for multiple date ranges. Display 20, 50 and 200 day moving averages and export charts as images to use in articles and blogs. The latest closing price for Meridian Bioscience as of August 17, 2018 is 14.90.
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.630B $0.201B
Meridian Bioscience, Inc. is a fully integrated life science company that manufactures, markets and distributes a broad range of innovative diagnostic test kits, purified reagents and biopharmaceutical enabling technologies that help deliver answers. Its products provide accuracy, simplicity and speed for the early diagnosis and treatment of common medical conditions, such as C. difficile, H. pylori, foodborne diseases and respiratory infections. In addition, the company develops and manufactures a variety of biological and non-biological materials used in proficiency testing programs. Meridian diagnostic products are used outside of the human body and require little or no special equipment. Meridian Bioscience designs their products to enhance the well-being of the patient-while reducing the total outcome costs of healthcare. Meridian has strong market positions in the areas of gastrointestinal infections, serology, parasitology and fungal disease diagnosis.
Stock Name Country Market Cap PE Ratio
Medtronic (MDT) Ireland $122.992B 19.04
Abbott Laboratories (ABT) United States $111.347B 23.33
Stryker (SYK) United States $62.374B 24.10
Boston Scientific (BSX) United States $48.250B 25.10
Baxter (BAX) United States $38.066B 25.91
Zimmer Biomet Holdings (ZBH) United States $24.970B 16.04
Smith & Nephew SNATS (SNN) United Kingdom $15.391B 0.00
ResMed (RMD) United States $15.293B 30.35
Bio-Rad Laboratories (BIO) United States $9.550B 61.33
Perrigo (PRGO) Ireland $9.502B 13.48
Canopy Growth (CGC) Canada $7.081B 0.00
Hill-Rom Holdings (HRC) United States $6.183B 20.97
ICU Medical (ICUI) United States $6.068B 41.12
Haemonetics (HAE) United States $5.344B 48.76
Insulet (PODD) United States $5.086B 0.00
Agios Pharmaceuticals (AGIO) United States $4.412B 0.00
Neogen (NEOG) United States $4.300B 68.52
Hutchison China MediTech (HCM) China $3.917B 0.00
GW Pharmaceuticals (GWPH) United Kingdom $3.681B 0.00
NuVasive (NUVA) United States $3.460B 32.82
National Vision Holdings (EYE) United States $3.019B 66.80
Quidel (QDEL) United States $2.740B 56.14
Phibro Animal Health (PAHC) United States $1.986B 29.49
NxStage Medical (NXTM) United States $1.857B 0.00
Cardiovascular Systems (CSII) United States $1.244B 747.80
Eagle Pharmaceuticals (EGRX) United States $1.173B 34.62
VAREX IMAGING (VREX) United States $1.111B 18.16
AtriCure (ATRC) United States $1.070B 0.00
Orthofix (OFIX) United States $0.999B 30.42
OraSure Technologies (OSUR) United States $0.982B 64.20
Omeros (OMER) United States $0.978B 0.00
Surmodics (SRDX) United States $0.969B 117.10
Cerus (CERS) United States $0.958B 0.00
TG Therapeutics (TGTX) United States $0.952B 0.00
Owens & Minor (OMI) United States $0.946B 10.12
MacroGenics (MGNX) United States $0.838B 0.00
PetIQ (PETQ) United States $0.767B 26.26
LeMaitre Vascular (LMAT) United States $0.710B 34.03
Insys Therapeutics (INSY) United States $0.555B 0.00
Lantheus Holdings (LNTH) United States $0.515B 16.01
Evolus (EOLS) United States $0.511B 0.00
NanoString Technologies (NSTG) United States $0.413B 0.00
Cytosorbents (CTSO) United States $0.346B 0.00
BioLife Solutions (BLFS) United States $0.324B 0.00
Utah Medical Products (UTMD) United States $0.321B 20.67
Quanterix (QTRX) United States $0.296B 0.00
Surface Oncology (SURF) United States $0.269B 0.00
Rockwell Medical (RMTI) United States $0.209B 0.00
Chimerix (CMRX) United States $0.194B 0.00
Fonar (FONR) United States $0.168B 10.19
Chembio Diagnostics (CEMI) United States $0.161B 0.00
Bovie Medical (BVX) United States $0.154B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.117B 0.00
Female Health (VERU) United States $0.115B 0.00
Trinity Biotech (TRIB) Ireland $0.090B 27.00
United-Guardian (UG) United States $0.086B 18.99
Oramed Pharmaceuticals (ORMP) Israel $0.083B 0.00
Neurotrope (NTRP) United States $0.077B 0.00
InfuSystems Holdings (INFU) United States $0.063B 0.00
Imprimis Pharmaceuticals (IMMY) United States $0.060B 0.00
CAS Medical Systems (CASM) United States $0.057B 0.00
ImmuCell (ICCC) United States $0.036B 0.00
Valeritas Holdings (VLRX) United States $0.035B 0.00
Capricor Therapeutics (CAPR) United States $0.033B 0.00
Akers Biosciences Inc (AKER) United States $0.025B 0.00
Myomo (MYO) United States $0.024B 0.00
Senestech (SNES) United States $0.021B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.015B 0.00
Cellectar Biosciences (CLRB) United States $0.010B 0.00
NeuroMetrix (NURO) United States $0.009B 0.00